Last updated: June 7, 2026
Who supplies dextrose 70% injection in a plastic container?
Dextrose 70% injection (D70W) is typically sourced from large sterile injectables manufacturers, contract manufacturers, and distributors supplying hospital and long-term care channels. Supply is usually standardized by presentation (plastic container) and by container type (commonly Viaflex-style flexible bags), with labeling differences by NDA/ANDA source.
What container type matters for dextrose 70% in plastic?
The phrase “in plastic container” usually maps to flexible container systems used for high-strength dextrose solutions. Key distinctions that affect supplier qualification and procurement:
Plastic container systems
- Flexible IV bags (common for high-concentration dextrose solutions)
- Multi-layer film bags (oxygen and moisture barrier characteristics)
- Ports and overwraps (for sterile transfer compatibility and handling)
Procurement teams typically lock vendors to:
- Container configuration
- Sterility and packaging system
- Case pack and barcoding/UDI (for hospital systems)
Which companies are major dextrose 70% injection suppliers?
A complete, defensible supplier list depends on the specific market (US vs. EU vs. Canada), package strength labeling (“70%” vs. “700 mg/mL”), and the exact container format used by the listed product. Without those scope constraints, any name list risks being incomplete or incorrect for the exact product configuration.
How many suppliers carry dextrose 70% injection in plastic bags?
The number of active suppliers varies by:
- Country and regulatory market
- Shortages and seasonal distribution
- Sterile-manufacturing capacity for high-strength glucose solutions
- Container line utilization (flexible bag systems)
What are the top distribution channels for dextrose 70% in plastic container?
Supplies generally move through:
- National wholesale distributors serving acute care
- Contract purchasing organizations (GPOs) and hospital procurement networks
- Direct-to-hospital fulfillment where manufacturers keep tighter inventory control during shortages
Key buying requirements:
- NDC and package configuration match
- Purchase-ready UDI compliance
- Expiration dating and temperature handling documentation
What does an accurate supplier qualification checklist look like?
Procurement and QA teams typically require:
- Exact NDC match for dextrose 70% in the specified plastic container
- Current GMP compliance record for sterile injectables
- Container integrity documentation (leak, seal, and port compatibility)
- Lot traceability, CoA, and sterility assurance documentation
- Packaging system validation status (bag material and closure system)
Does dextrose 70% have FDA approvals that limit suppliers?
In the US, sterile injectables are marketed under specific approved product applications and listed NDCs. Supplier availability for the “plastic container” presentation is constrained by:
- The approved manufacturer’s sterile fill-finish and container line
- Approved labeling and manufacturing process controls
- Ongoing supply chain continuity for the container supplier and bag system
What supply risks exist for dextrose 70% in plastic containers?
Common disruption points:
- Container film and closure supply for flexible bag systems
- Sterile fill-finish capacity for high-strength dextrose solutions
- Quality hold actions and sterility investigation outcomes
- GxP inspection findings that restrict lot release
How do suppliers price and allocate during shortages?
When allocations occur, pricing and ordering are typically driven by:
- Contract terms through wholesalers and GPOs
- Allocation caps by facility or distributor
- Lead times for replenishment and container line scheduling
Key Takeaways
- Dextrose 70% injection in a plastic container is supplied through sterile injectables manufacturers and distributor channels that can support the specific flexible container system used for the product.
- Supplier qualification must be NDC- and container-system-specific, not just “70% dextrose.”
- Supply risk concentrates around flexible bag container materials, sterile fill-finish capacity, and lot-release constraints.
FAQs
1) How do I verify the exact product match for dextrose 70% in a plastic container?
Match the NDC and label description for “dextrose 70% injection” and confirm container type (flexible bag) and presentation in the order spec.
2) Are dextrose 70% suppliers interchangeable across different container systems?
No. Even with the same strength, different container types or ports can trigger incompatibility with facility transfer sets or workflow.
3) What documentation should hospitals require from suppliers?
CoA per lot, expiration dating, sterility assurance documentation, lot traceability, and UDI labeling compliance for the shipped NDC.
4) What drives manufacturing capacity for dextrose 70%?
The sterile fill-finish line schedule and the ability to supply compliant flexible bag systems for high-strength dextrose solutions.
5) How do shortages typically impact dextrose 70% availability?
Allocations, longer lead times, and increased substitution risk at the distributor level, unless procurement locks to exact NDC and container format.**
References
No sources were provided in the prompt, and no in-scope, product-specific supplier dataset (country, NDCs, container brand/system) was given to support a factual supplier list.
